Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
822.9500 16.40 (2.03%)
NSE Oct 03, 2025 15:13 PM
Volume: 297.6K
 

logo
Natco Pharma Ltd.
16 Nov 2015
822.95
2.03%
Reliance Securities
3. gSovaldi contributed Rs630mn in 2Q (Rs230mn from B2B business) with operating margins at 28-30%. We believe Sovaldi is an interesting opportunity for the Indian market and Natco's first mover advantage will give it a significant...
Number of FII/FPI investors decreased from 385 to 317 in Jun 2025 qtr
More from Natco Pharma Ltd.
Recommended